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Introduction {#sec005}
============

Pharmacy practice system is the responsible provision of drug therapy to achieve a definitive outcome that improves patients\' quality of life. The role of the pharmacist has evolved substantially in recent decades from traditional roles of compounding and dispensing of medication to providing direct patient care to ensure the rational and cost-effective use of medicines, including the promotion of equally effective and less expensive generic medicines utilization \[[@pone.0235205.ref001]\].

A generic drug is defined as "a pharmaceutical product, usually intended to be interchangeable with the branded medicine. It can only be manufactured after a patent protection expires of the branded medicine. Generics medicines are also considered as therapeutically equivalent to their counterpart branded drugs" \[[@pone.0235205.ref002]\].

Generic drugs become available after patent protection for branded drugs has expired. After the expiry of patent protection, the generic drugs could be manufactured by companies other than the innovator company \[[@pone.0235205.ref003]\]. Generic medicine is the same as its comparator branded medicine in terms of safety, quality, efficacy, dosage form, strength, route of administration, and intended use \[[@pone.0235205.ref004]--[@pone.0235205.ref007]\]. Nevertheless, they may be different in some other aspects including shape and packaging \[[@pone.0235205.ref008]\].

Generic medicines are typically 20 to 90% cheaper than their brand equivalent. Since the cost for drug discovery, pre-clinical and clinical trials, as well as for some other reasons will not be considered and patent rights will no longer be protected, generics usually sold at a far lower price. Hence, generic medicine is an economical alternative to more expensive branded medicine and in reducing pharmaceutical monetary expenditures \[[@pone.0235205.ref009], [@pone.0235205.ref010]\]. Generic substitution is considered as cost minimization strategy, by government and other third-party payers, to contain pharmaceutical expenditure \[[@pone.0235205.ref011]--[@pone.0235205.ref015]\].

Currently, several countries around the world advocate generic utilization by instigating different policies, initiatives, and strategies. Many countries allow or authorize pharmacists to substitute a generic version (if one is available) whenever a physician prescribed. This flexibility is imperative to promote generic medicines utilization \[[@pone.0235205.ref016]--[@pone.0235205.ref021]\].

In Ethiopia, the use of generic names of drugs in prescription is enforced by clinical practice guidelines \[[@pone.0235205.ref022]\]. Besides, the pharmacist has the right to dispense generic drugs as substitutes for prescribed branded drugs as on national drug policy \[[@pone.0235205.ref023]\].

Generic prescribing and generic substitution have been controversial. Furthermore, the acceptance and promotion of generic medicines among healthcare professionals has been the main concern \[[@pone.0235205.ref024]--[@pone.0235205.ref026]\]. Issues related to quality, safety, and efficacies of the generic medicines are of top of concerns \[[@pone.0235205.ref025], [@pone.0235205.ref027], [@pone.0235205.ref028]\]. Misinformation or inadequate knowledge of healthcare professionals regarding generics causes' hesitation on the utilization of generics and it has been the central challenge against wider use of these products \[[@pone.0235205.ref029]\]. Thus, it is crucial to analyze the knowledge and attitude of health professionals regarding generic medicines which is a prerequisite to encourage its utilization \[[@pone.0235205.ref006], [@pone.0235205.ref028]\].

Pharmacists are the main determinants in consumer choice to the rational use of generics, according to a study on consumers' perception \[[@pone.0235205.ref030]\]. A previous study in Ethiopia employed pharmacists has revealed that more than half (52.9%) of participants had known that generic medicine is bioequivalent to branded medicine and 34.4% of respondents have believed generic medicines are less effective \[[@pone.0235205.ref031]\]. This research can provide evidence of the community pharmacists' knowledge, attitude and practice toward generic medicines and to identify factors associated with generic medicines dispensing in Ethiopia. The findings may assist policymakers regarding generic substitution in the future.

Materials and methods {#sec006}
=====================

Study design and setting {#sec007}
------------------------

In this cross-sectional survey conducted on the facility-based census, a questionnaire was distributed to all community pharmacists in Harar city from September to October 2018. The study was conducted in all community drug retail outlets (CDROs) in Harar City. The city is located in Harari regional state, which is about 526 km away in the Eastern direction from Addis Ababa, the capital of Ethiopia. According to the report from the 2007 national population and housing census, the city had an estimated total population of 183,344 (ECSA, 2007). Harar city has 45 drug stores and 16 community pharmacies.

### Sample size {#sec008}

All community drug retail outlets in Harar were considered and all pharmacy professionals working in CDROs were included. Accordingly, there are 61 community drug retail outlets in Harar city and approximately around 90 pharmacy professionals are working in community drug retail outlets. Among those, 80 of them were volunteered to participate in the study.

The study tool {#sec009}
--------------

A self-administered thirty three-item questionnaire on Knowledge, attitude, and practice of community pharmacists toward generic medication was developed after an extensive review of available literature related to the topic \[[@pone.0235205.ref027], [@pone.0235205.ref028], [@pone.0235205.ref030]\]. The questionnaire was prepared in English. This was translated to Amharic followed by back translation to English to ensure that the translated version gives the right meaning. The tool has two-part with the first part contained socio-demographic information of study participants. Part two questions were to assess their knowledge, attitude and practice regarding generic medicines and were assessed using the 5-point Likert scale (1 = strongly agree to 5 = strongly disagree). Questions assessing the knowledge had only one \"correct" answer and each correct answer worth one point. The total knowledge score which ranged from 8--40 was used to classify knowledge into adequate knowledge (24--40) and inadequate knowledge which is a score of less than the average score (8--23). Question on attitude had 9--45 total score that used to delineate between negative and positive attitude while 27 took as cut off point. Negatively worded questions were reverse scored during the analysis so that the higher scores reflected a more positive attitude towards generic medicines. The questionnaire was pretested on 5% of community pharmacists in Gurawa town, which is a town near Harar city and necessary modifications were instituted to final data collection tool depending on the feedback obtained from the pilot study. Data were collected by three pharmacy professionals and adequate training was provided to data collectors on contents of the questionnaire, data collection methods and ethical concerns by the principal investigator. Questionnaires were collected three days from the date of distribution.

Data analysis {#sec010}
-------------

The responses from each study participants were manually entered into Statistical Package for Social Studies (SPSS) version 21.0 and were double-checked for accuracy. Descriptive aspects of analyses were done through calculating mean, standard deviation, frequencies, and percentages. Bivariate logistic regression analysis was done to predict the determinants of knowledge and attitude towards generic medicines. Variables with a p-value of less than 0.2 were included in the multivariate logistic regression analysis. Odds ratio with 95% confidence interval (95% CI) were also computed along with corresponding *p*-value (*p*\<0.05).

Ethical considerations {#sec011}
----------------------

Ethical clearance was secured from the institutional research board, School of Pharmacy at Haramaya University. The purpose and importance of the study were explained to and written consent was obtained from each study participant before proceeding to query. Furthermore, other issues relating to the ethical conduct of research: such as confidentiality, privacy was upheld.

Result {#sec012}
======

Socio-demographic and work profiles {#sec013}
-----------------------------------

Out of 80 community pharmacists' approached, 74 completed the survey (response rate- 92.5%). More than half (55.4%) participants were female and within age group of 20--29 years (54.1%). Around two-third (63.5%) of the respondents held diploma in pharmacy and worked as an employee in community pharmacy (60.8%). Sixty-one (82.4%) of the respondents were not Ethiopian Pharmacists Association (EPA) member and only about one-fourth of participants (24.3%) had above 5 years' experience in community pharmacy practice ([Table 1](#pone.0235205.t001){ref-type="table"}).

10.1371/journal.pone.0235205.t001

###### Socio-demographic characteristics of the community pharmacists in Harar, Eastern Ethiopia 2018.

![](pone.0235205.t001){#pone.0235205.t001g}

  Variables                                                Frequency (%)
  -------------------------------------------------------- ---------------
  **Age**                                                  
  20--29 years                                             40(54.1)
  30--39 years                                             26(35.1)
  40 and above years                                       8(10.8)
  **Sex**                                                  
  Male                                                     33(44.6)
  Female                                                   41(55.4)
  **Qualification**                                        
  Diploma                                                  47(63.5)
  Degree                                                   21(28.4)
  MSc                                                      6(8.1)
  **Employment position**                                  
  Pharmacy /drug store owner                               26(35.1)
  Employee                                                 45(60.8)
  Others                                                   3(4.1)
  **Education Institution**                                
  Private institution                                      48(64.9)
  Government/public institution                            26(35.1)
  **Ethiopian pharmacists association (EPA) membership**   
  Yes                                                      13(17.6)
  No                                                       61(82.4)
  **Work experience**                                      
  Less than 2 years                                        29(39.2)
  2--5 years                                               27(36.5)
  Greater than 5 years                                     18(24.3)

Pharmacy professionals' knowledge on generic medicines {#sec014}
------------------------------------------------------

In our study, majority (86.5%) of participants knew that generic medicines are cheaper than branded medicines and they are bioequivalent to branded medicines (67.6%). On the other hand, more than one-third (39.2%) of participants did not support the idea that extensive use of generic medicines in Ethiopia helps in minimizing the country's health care expenditure ([Table 2](#pone.0235205.t002){ref-type="table"}).

10.1371/journal.pone.0235205.t002

###### Knowledge of community pharmacists about generic medicine in Harar, Eastern Ethiopia 2018.

![](pone.0235205.t002){#pone.0235205.t002g}

  Variables                                                                                              Strongly disagree (%)   Disagree (%)   Neutral (%)   Agree (%)   Strongly agree (%)
  ------------------------------------------------------------------------------------------------------ ----------------------- -------------- ------------- ----------- --------------------
  A generic medicine is bioequivalent to branded medicine                                                10(13.5)                5(6.8)         9(12.2)       29(39.2)    21(28.3)
  generic medicine must contain the same amount of active ingredients as the branded medicine            6(8.1)                  8(10.8)        6(8.1)        35(47.3)    19(25.7)
  A generic medicine must be in the same dosage form to the branded medicine                             5(6.8)                  14(18.9)       11(14.9)      26(35.1)    18(24.3)
  Generic medicines are cheaper than branded medicines                                                   4(5.4)                  4(5.4)         2(2.7)        43(58.1)    21(28.4)
  Wider use of generic medicines in Ethiopia helps in decreasing the country's health care expenditure   17(23)                  12(16.2)       13(17.5)      15(20.3)    17(23)
  Community pharmacists in Ethiopia have the right to perform generic substitution                       8(10.8)                 9(12.2)        7(9.5)        32(43.2)    18(24.3)
  Generic substitution of medicines with narrow therapeutic index is inappropriate                       9(12.2)                 8(10.8)        4(5.4)        32(43.2)    21(28.4)
  In Ethiopia, generic medicines are approved by FMHACA as brand medicines                               6(8.1)                  8(10.8)        7(9.5)        35(47.3)    18(24.3)

Knowledge of community pharmacists and associated factors {#sec015}
---------------------------------------------------------

In multivariate logistic regression, only work experience has shown statistically significant association with knowledge level. Pharmacists with 5 or more years' experience in community pharmacy practice were more likely to have adequate knowledge (AOR = 2.18, 95%CI:1.21--63.1). The remained socio-demographic and work profiles were not significantly associated with knowledge level of respondents, both in bivariate and multivariate logistic regression analysis ([Table 3](#pone.0235205.t003){ref-type="table"}).

10.1371/journal.pone.0235205.t003

###### Predictors of knowledge level of community pharmacists on generic medicines in Harar, Eastern Ethiopia 2018.

![](pone.0235205.t003){#pone.0235205.t003g}

                                  Knowledge on generics                                 
  ------------------------------- ----------------------- ---- ------------------------ ---------------------
  **Sex**                                                                               
  Male                            14                      19   1                        1
  Female                          22                      19   1.57(0.53--1.603)        0.46(0.29--3.951)
  **Age**                                                                               
  20--29 years                    19                      21   1                        1
  30--39 years                    15                      11   1.507(0.66--20.5)        0.297(0.014--6.078)
  40 and above years              2                       6    2.71(0.41--1.449)        0.520(0.06--44.7)
  **Qualification**                                                                     
  Diploma                         13                      25   1                        1
  Degree                          9                       11   1.57(0.363--13.01)       0.689(0.3--14.7)
  MSc                             4                       2    3.84(0.61--16.547)       7.044(0.35--140.01)
  **Employment position**                                                               
  Partime /full-time owner        5                       21   1                        1
  Employee                        30                      15   0.11(0.057--28.02)       0.87(0.547--5.94)
  Others                          1                       2    2.1(0.02--2.983)         1.82(0.12--61.23)
  **Education Institution**                                                             
  Private institution             34                      14   1                        1
  Government/public institution   24                      2    4.94(0.318--8.922)       7.1(0.8--23.21)
  **EPA membership**                                                                    
  Yes                             6                       7    1.35(0.267--2.942)       1.7(0.057--50.729)
  No                              31                      30   1                        1
  **Work experience**                                                                   
  Less than 2 years               19                      10   1                        1
  2--5 years                      5                       22   8.36(0.657--21.74)       5.87(0.054--41.54)
  Greater than 5 years            12                      6    1.052(1.012--20.085)\*   2.18(1.21--63.1)\*

Pharmacists' attitudes toward generic medicines {#sec016}
-----------------------------------------------

Among study participants, around half (48.6%) believed that generic medicines are less effective than brand medicines and more than average (56.8%) revealed that branded medicines are of higher quality. Thirty-five (41.9%) participants disagreed generics has a slower onset of action and fifty percent of respondents cited the differences in prices between branded and generic versions as a reason for generic substitution ([Table 4](#pone.0235205.t004){ref-type="table"}).

10.1371/journal.pone.0235205.t004

###### An attitude of community pharmacists towards generic medicines in Harar, Eastern Ethiopia 2018.

![](pone.0235205.t004){#pone.0235205.t004g}

  Variables                                                                                                                                                                              Strongly disagree (%)   Disagree (%)   Neutral (%)   Agree (%)   Strongly agree (%)
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------- -------------- ------------- ----------- --------------------
  Generic medicines are less effective than branded medicines                                                                                                                            6(8.1)                  23(31.1)       9(12.2)       26(35.1)    10(13.4)
  Branded medicines are of higher quality compared to generic drugs                                                                                                                      6(8.1)                  18(24.3)       8(10.8)       23(31.1)    19(25.7)
  Generic drugs produce more side effects than brand name medicines                                                                                                                      23(31.1)                22(29.7)       9(12.2)       12(16.2)    8(10.8)
  Generic medicine has slow onset of action                                                                                                                                              18(24.3)                13(17.6)       5(6.8)        30(40.5)    8(10.8)
  I support generic substitution for branded medicines in all cases where a generic is available                                                                                         14(18.9)                7(9.5)         17(23)        19(25.6)    17(23)
  The price difference between generic and branded medicine would be good reason to dispense generics especially for people who do not have prescription medicine benefits in Ethiopia   8(10.8)                 16(21.6)       13(17.6)      33(44.6)    4(5.4)
  Patients should be briefed on the reasons for choosing generic medicines                                                                                                               9(12.2)                 3(4.1)         10(13.5)      38(51.4)    14(18.8)
  The intensity of promotional activities by medical representatives is crucial for dispensing generics                                                                                  5(6.8)                  15(20.3)       6(8.1)        23(31.1)    25(33.7)
  Community pharmacists should be allowed to perform generic substitutions without consulting prescribing physicians                                                                     11(14.9)                15(20.3)       10(13.5)      30(40.5)    8(10.8)

### Pharmacists' attitude and associated factors {#sec017}

In this study, female pharmacy professionals were more likely to have a positive attitude toward generic medicines in multivariate logistic regression (AOR = 3.88, CI: 2.12--39.623). The remained socio-demographic and work profiles have not revealed a significant association with pharmacists' attitude towards generic medicines ([Table 5](#pone.0235205.t005){ref-type="table"}).

10.1371/journal.pone.0235205.t005

###### Predictors of attitude of community pharmacists towards generic medicines, Harar, Ethiopia, 2018.

![](pone.0235205.t005){#pone.0235205.t005g}

  Attitude on generics                                               
  ------------------------------- ---- ---- ------------------------ ----------------------
  **Sex**                                                            
  Male                            15   18   1                        1
  Female                          34   7    5.829(2.012--16.884)\*   3.88(2.12--39.623)\*
  **Age**                                                            
  20--29 years                    34   10   1                        1
  30--39 years                    10   12   4.08(0.099--2.417)       0.686(0.071--6.636)
  40 and above years              5    3    2.04(0.381--10.511)      0.855(0.075--9.756)
  **Qualification**                                                  
  Diploma                         31   17   1                        1
  Degree                          13   7    1.018(0.296--25.424)     7.805(0.434--38.219)
  MSc                             5    1    2.74(0.261--27.821)      2.453(0.116--52.063)
  **Employment position**                                            
  Partime /full-time owner        16   10   1                        1
  Employee                        31   14   0.72(0.1--15.647)        0.287(0.04--19.534)
  Others                          2    1    0.80(0.075--10.808)      0.88(0.015--53.059)
  **Education Institution**                                          
  Private institution             34   14   1                        1
  Government/public institution   15   11   1.78(0.207--1.521)       4.627(0.126--169.57)
  **EPA membership**                                                 
  Yes                             7    6    1                        1
  No                              42   19   1.895(0.561--6.403)      0.460(0.02--9.710)
  **Work experience**                                                
  Less than 2 years               19   10   1                        1
  2--5 years                      15   12   1.52(0.613--11.298)      6.1(0.73--23.190)
  More than 5 years               15   3    3.1(0.935--17.113)       0.591(0.324--76.92)
  **Knowledge on generics**                                          
  No                              23   15   1                        1
  Yes                             26   10   0.59(0.222--1.567)       0.4(0.073--2.182)

### Pharmacy professionals' views toward locally manufactured generic medicines {#sec018}

In present study, forty-six percent (agree = 20.3%, strongly agree 25.7%) of the respondents claimed that locally manufactured generics are similar in quality to the imported generics and refused the idea that manufacturers of local generic products have a reliable logistic and supply system (44.6%). From respondents, more than half (56.7%) of believed that locally manufactured generics are equal in safety and efficacy compared to the imported generics and claimed that locally manufactured generics are cheaper (77%) \[[Table 6](#pone.0235205.t006){ref-type="table"}\].

10.1371/journal.pone.0235205.t006

###### View of community pharmacists towards locally manufactured medicines in Harar, Ethiopia 2018.

![](pone.0235205.t006){#pone.0235205.t006g}

  Variables                                                                                                                Strongly disagree (%)   Disagree (%)   Neutral (%)   Agree (%)   Strongly Agree (%)
  ------------------------------------------------------------------------------------------------------------------------ ----------------------- -------------- ------------- ----------- --------------------
  Locally manufactured generics are equal in quality compared to the imported generics                                     7(9.5)                  16(21.6)       17(23)        15(20.3)    19(25.7)
  Locally manufactured generics are equal in safety and efficacy to the imported generics                                  11(14.9)                8(10.8)        13(17.6)      26(35.1)    16(21.6)
  Manufacturers of local generic products have a reliable logistic and supply system                                       21(28.4)                12(16.2)       7(9.5)        13(17.6)    21(28.4)
  I prefer to stock and dispense locally manufactured generics because of the financial incentives provided by companies   19(25.7)                26(35.1)       15(20.3)      7(9.5)      7(9.5)
  Credibility of the generic manufactures/suppliers is my concern when stocking medicines in my pharmacy                   15(20.3)                13(17.6)       12(16.2)      22(29.7)    12(16.2)
  I will only stock locally manufactured product which is well advertised by the company.                                  15(20.3)                18(24.3)       13(17.6)      12(16.2)    16(21.6)
  Imported generics need to pass a more stringent approval process compared with locally manufactured ones.                8(10.8)                 13(17.6)       14(18.90      30(40.5)    9(12.2)
  Locally manufactured generics are cheaper compared to imported generics.                                                 6(8.1)                  7(9.5)         4(5.4)        26(35.1)    31(41.9)
  Drug Regulatory Authorities need to convince pharmacists on higher quality of locally manufactured generics              7(9.5)                  15(20.3)       10(13.5)      29(39.2)    13(17.6)

Influencing factors related to selection and dispensing of generic medicines {#sec019}
----------------------------------------------------------------------------

In this study, more than half (54%) of study participants revealed their lack of belief in generic medicine as an important factor that deters selection and dispensing of generic medicines. From participants, fifty-eight (78.3%) and sixty-four (86.5%) of them declared affordability to customer and cost-effectiveness of generic medicines as determinant factors for selection and dispensing of generic medicines, respectively \[[Table 7](#pone.0235205.t007){ref-type="table"}\].

10.1371/journal.pone.0235205.t007

###### Possible factors to influence selection and dispensing of generic medicines among the community pharmacists in Harar, Ethiopia 2018.

![](pone.0235205.t007){#pone.0235205.t007g}

  Variables                                      Not important (%)   Neutral (%)   Important (%)
  ---------------------------------------------- ------------------- ------------- ---------------
  Lack of belief in generic medicines            17(23)              17(23)        40(54)
  Availability of policies, laws & regulations   25(33.8)            9(12.2)       40(54)
  Affordability to the customer                  9(12.2)             7(9.5)        58(78.3)
  Lacking options                                44(59.5)            5(6.8)        25(33.7)
  Consumer preference/ demand                    99(25.7)            18(24.3)      37(50)
  Cost-effectiveness of generic medicines        6(8.1)              4(5.4)        64(86.5)
  Substitution agreement with the prescriber     19(25.7)            9(12.2)       46(62.1)

Discussion {#sec020}
==========

This study tried to assess the knowledge, attitude, and practice of community pharmacists toward generic medicines and also their views toward locally produced generic medicine in Ethiopia. The finding this study shows that there are gaps in knowledge, attitude, and practice of community pharmacy professionals towards generic medicines, which is corroborated by the previous studies \[[@pone.0235205.ref030], [@pone.0235205.ref031]\]. This could be explained by pharmacy professionals' individualized knowledge and attitudes towards generic medicines.

In this study, fifty (67.6%) of the respondents agreed that generic medicines are bioequivalent to their counterpart branded medicines, which is likely to a study finding in New Zealand (70%) \[[@pone.0235205.ref025]\]. However, it was higher compared to findings from a previous studies conducted in Northern Ethiopia (52.9%) \[[@pone.0235205.ref031]\] and Malaysia (50.2%) \[[@pone.0235205.ref032]\].

In this study, sixty-four (86.5%) of study subjects claimed that generic medicines are cheaper than branded medicines, which is comparable with the finding of a study conducted in Australia (91.3%) \[[@pone.0235205.ref033]\]. In addition, more than half (59.4%) of the participants knew that generic medicines must be in the same dosage form as the branded medicines, which is comparable with a study conducted by Yared et al. (64.3%) \[[@pone.0235205.ref031]\]. In contrast, it was much lower as compared to a study in Australia (84.1%) \[[@pone.0235205.ref033]\]. This could be due to educational variance between respondents employed in two studies.

Our study revealed that most (67.5%) of pharmacists know their right to perform the generic substitution. This was much lower than Allenet et al.'s study that announced 90% of the pharmacists were agreed with pharmacists' right of generic medicines substitution \[[@pone.0235205.ref034]\]. This could be explained by the better progress of pharmacy care practice in France. In multivariate logistic regression, only work experience had a statically significant association with knowledge level of respondents and it showed that pharmacists with 5 or more years of experience were more likely to have adequate knowledge (AOR = 2.18, 95% CI: 1.21--63.1). This could be due to the fact, as the number of years of practice increases, pharmacists are more likely to be exposed to different local generics manufacturing pharmaceutical companies and local health authorities\' provided information on generic medicines.

In this study, more than one-third (39.2%) of respondents were disagreed with the myth that generic medicines are less effective than branded medicines, which was much lower than reports of Yared et al. (50%) \[[@pone.0235205.ref031]\] and Hassali et al. (58.4%) \[[@pone.0235205.ref032]\]. This implicates the better perception of generic medicines in Malaysia and even in Northern Ethiopia than the study area, which indicates the need to promote generic medicines in Harar city.

In our study, more than half (56.8%) of respondents support the concept of branded medicines are of higher quality, which is comparable to a study report from Mekelle (51.7%) \[[@pone.0235205.ref031]\], but far lower than in Australian comparative study of senior medical students and pre-registrant pharmacists (89.6%) \[[@pone.0235205.ref033]\]. This might be due to the inclusion of both junior and senior pharmacists in our study, unlike Australian study which employed only pre-registrants pharmacists. Nevertheless, the finding is much lower than Othman et al.'s study on pharmacy students in Yemeni, in which 98% and 96% of pharmacists accepted the idea that generics are similar in quality and as effective as branded medicines, respectively \[[@pone.0235205.ref035]\]. The probable explanation to this discrepancy might be due to students' familiarity to basic science than working pharmacy professionals.

In current study, around half (51%) of study participants stated that pharmacists should be allowed to make a generic substitution without consulting physicians. This finding is comparable to a previous study report (50.5%) \[[@pone.0235205.ref031]\]. In contrast, it was lower than a study in Turkey in which 55% of the respondents claimed that pharmacists may substitute a generic without consulting the prescribers \[[@pone.0235205.ref036]\].

Among study participants, forty (54.1%) of them claimed their lack of belief in generic medicines as a determinant factor that affects the dispensing of generic medicines. This is higher compared with a previous study report from Northern Ethiopia 48.3% \[[@pone.0235205.ref031]\]. This pharmacists' high level of lack of belief on generics indicates that correcting inappropriate belief of pharmacy professionals toward generic medicines should be the main concern for all stakeholder including pharmaceutical association in the country, to ensure generic dispensing practice in Ethiopia.

From study participants, sixty-four (86.5%) of them declared cost-effectiveness of generic medicines as a significant factor in dispensing of a generic products. This was higher than Yared et al.'s study in northern Ethiopia (73.6%) \[[@pone.0235205.ref031]\]. However, it was lower than the finding of a study conducted in Australia (91.3%) \[[@pone.0235205.ref033]\]. The discrepancy with Australia could be due to the sustainability of generic medicines which decrease the price of generic medicine in Australia.

Furthermore, thirty-four (46%) of study participants revealed that locally manufactured generics are equal in quality to the imported generics. This is comparable with Bashaar et al.'s study in which 47.5% of participants have supported the concept of locally manufactured generics are equal in quality to imported generics \[[@pone.0235205.ref037]\]. However, it is lower compared to a finding of a study conducted in Mekelle \[[@pone.0235205.ref031]\], which could be due to the presence of local generic manufacturing pharmaceutical companies and associated exposure to generic related information in northern Ethiopia. Thus, recommended to local generic manufacturing pharmaceutical companies to address their promotion to the area with no pharmaceutical company including the Eastern part of the country.

In the present study, fifty-seven (77%) of the respondents accepted the idea that locally manufactured generics are cheaper than imported generics and thirty-two (56.7%) of them agreed that locally manufactured generics are equal in safety and efficacy to imported generics. This finding is lower than a report from a study performed in Malaysia (58.4%) \[[@pone.0235205.ref032]\]. Future studies are warranted to explore the potential intervention to address the gaps in knowledge, attitude, and practice of pharmacy professionals on generic medicines. Finally, qualitative research on the area with in-depth interviews is required to comprehend the real-life barriers to dispense generics that the pharmacists are facing in Ethiopia.

Conclusions {#sec021}
===========

The current study revealed that there is a gap in the knowledge, attitude, and practice of community pharmacists towards generic and brand drugs. Despite this, more than averages of the respondents were knowledgeable on the concept of generic medicine, including their right to perform generic substitution and had a positive attitude toward generics. In multivariate analysis, female pharmacists were more likely to have a positive attitude and overall knowledge was higher in those who have more than 5 years of work experience. More than half of the study participants claimed the lack of belief in generic medicines as significant factors that affect the selection and dispensing of generics.
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Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Apr 04 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Joseph Telfair, DrPH, MSW, MPH

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements:

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at <http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf> and <http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified whether consent was written or verbal/oral. If consent was verbal/oral, please specify: 1) whether the ethics committee approved the verbal/oral consent procedure, 2) why written consent could not be obtained, and 3) how verbal/oral consent was recorded. If your study included minors, please state whether you obtained consent from parents or guardians in these cases.

3\. Please include copies of the survey questions or questionnaires used in the study, in both the original language and English, as Supporting Information, or include a citation if they have been published previously.

4\. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:

<https://www.jbclinpharm.org/articles/assessment-of-knowledge-attitude-and-practice-of-pharmacy-professionals-toward-generic-medicines-northern-ethiopia-mekelle-a-cross-3923.html>

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the Methods section. Further consideration is dependent on these concerns being addressed.

5\. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (<http://learn.aje.com/plos/>) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website ([www.editage.com](http://www.editage.com)) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

The name of the colleague or the details of the professional service that edited your manuscriptA copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a \*supporting information\* file)A clean copy of the edited manuscript (uploaded as the new \*manuscript\* file)

 

6\. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript.

7\. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 2 in your text; if accepted, production will need this reference to link the reader to the Table.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: No

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: This is an interesting study to uncover the knowledge, beliefs and attitudes among pharmacists in Ethiopia and other related professionals, about the value of generic drugs. The approach and methods are well described. The authors should describe the pharmacy practice system at the beginning, so that the results are put in the context of pharmacy practice and can be better interpreted.

In the discussion, there should also be a more thorough explanation of the \'so what\' and the next steps.

In general, there are many grammatical and typographical errors that needs to be corrected, and the formatting should be improved.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0235205.r002
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Editor(s)' decision and comments

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Our answer: thank you for your consideration of its merit and offer.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

Our answer: thank you. No change in financial disclosure

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Our answer: thank you. It is not applicable

Response to editor

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at <http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf> and <http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

Our Answer: Thank you for this comment. The revised manuscript version is formatted in strict adherence to PLOS ONE's formatting guideline, which obtained from above URL address, including file naming, font size for each section, spacing and other required format.

2\. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified whether consent was written or verbal/oral. If consent was verbal/oral, please specify: 1) whether the ethics committee approved the verbal/oral consent procedure, 2) why written consent could not be obtained, and 3) how verbal/oral consent was recorded. If your study included minors, please state whether you obtained consent from parents or guardians in these cases.

Our answer: Thank you for rising this point. Since the study participants are expected to read and write, written informed consent was obtained from all subjects before proceeding to query, which was approved by ethical review committee. During the informed consent process, study participants were assured that data collected would be used only for stated purposes and would not be disclosed or released to others without the consent of the participants. All study participants was adults, pharmacy professionals.

3\. Please include copies of the survey questions or questionnaires used in the study, in both the original language and English, as Supporting Information, or include a citation if they have been published previously.

Our answer: Thank you for this comment. The questionnaire used in this study is not published anywhere, but the literature we derived it from were adequately cited and it is provided as supplementary material both in local language and English upon submission.

4\. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:

<https://www.jbclinpharm.org/articles/assessment-of-knowledge-attitude-and-practice-of-pharmacy-professionals-toward-generic-medicines-northern-ethiopia-mekelle-a-cross-3923.html>. In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the Methods section. Further consideration is dependent on these concerns being addressed.

Our answer: thank you for rising this point. We have checked the manuscript for any possible overlapping text to different source including the one you have indicated above and the obtained overlapping text were rephrased and synthesized using authors' specific language

5\. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.

Our answer: thank you for this comment. After copyediting the manuscript thoroughly, we have tried to address all typographical and grammatical errors in the manuscript. The grammatical and typographical errors within manuscript was addressed in collaboration with my colleagues

6\. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript.

Our answer: we have moved the ethics statement from declaration section to method section of the manuscript.

7\. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 2 in your text; if accepted, production will need this reference to link the reader to the Table.

Our answer: we have included citation of table2 in the text prior to the table as per your recommendation.

Reviewers comment and decision

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Response to reviewer

Reviewer \#1: This is an interesting study to uncover the knowledge, beliefs and attitudes among pharmacists in Ethiopia and other related professionals, about the value of generic drugs. The approach and methods are well described. The authors should describe the pharmacy practice system at the beginning, so that the results are put in the context of pharmacy practice and can be better interpreted.

In the discussion, there should also be a more thorough explanation of the \'so what\' and the next steps.

In general, there are many grammatical and typographical errors that needs to be corrected, and the formatting should be improved

Our answer: thank you for your appreciation and offer. Pharmacy practice system is described at the beginning of manuscript including its relation with generic drug utilization and we have tried to put and interpret the result in context of pharmacy practice system. In discussion, we have included that what should be done per our each finding and at the end of discussion, future direction for studies that will be conducted on the area. After looking the manuscript thoroughly, we have tried to address all grammatical and typographical errors in manuscript and the revised version of manuscript is formatted in strict adherence to PLOS ONE's formatting style including naming of file.

###### 

Submitted filename: Response to reviewers.docx

###### 

Click here for additional data file.

10.1371/journal.pone.0235205.r003
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Knowledge, Attitude and Practice of Pharmacy Professionals on Generic Medicines in Eastern Ethiopia: A Cross-Sectional Study

PONE-D-19-29738R1

Dear Dr. Mohammed,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Joseph Telfair, DrPH, MSW, MPH

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

10.1371/journal.pone.0235205.r004
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Telfair

Joseph

Academic Editor

© 2020 Joseph Telfair

2020

Joseph Telfair

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

1 Jul 2020

PONE-D-19-29738R1

Knowledge, attitude, and practice of pharmacy professionals on generic medicines in Eastern Ethiopia: A cross-Sectional Study

Dear Dr. Mohammed:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Joseph Telfair

Academic Editor

PLOS ONE
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